Antibodies Incorporated is proud to announce our collaboration with Gregory Kapatos, Ph.D. to develop antibodies against critical targets modulating gene expression. Dr. Kapatos personally developed the best-selling anti-tyrosine hydroxylase antibody LNC1 and brings a wealth of experience to help guide our antibody development efforts.
The 71st AACC meeting will take place August 4-8, 2019 at the Anaheim Convention Center in California. The American Association for Clinical Chemistry (AACC) organizes the conference, and all members of the global laboratory medicine community are welcome to attend. The conference is a chance to connect with global leaders in the sciences, learn about new technology, and important changes in the field. Attendees will also examine advances in medicine in the context of our changing healthcare environment.